Dioxin hepatic carcinogenesis: Biologically motivated modeling and risk assessment
- 1 May 1993
- journal article
- Published by Elsevier in Toxicology Letters
- Vol. 68 (1-2) , 177-189
- https://doi.org/10.1016/0378-4274(93)90129-l
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Comparison of the nuclear and cytosolic forms of the Ah receptor from Hepa 1c1c7 cells: Charge heterogeneity and ATP binding propertiesArchives of Biochemistry and Biophysics, 1991
- Targets for Dioxin: Genes for Plasminogen Activator Inhibitor-2 and Interleukin-1βScience, 1991
- A physiological pharmacokinetic description of the tissue distribution and enzyme-inducing properties of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the ratToxicology and Applied Pharmacology, 1990
- TCDD (2, 3, 7, 8‐tetrachlorodibenzo‐p‐dioxin) is a tight binding inhibitor of cytochrome p‐450DJournal of Biochemical Toxicology, 1989
- Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxinArchives of Toxicology, 1988
- A physiologically based pharmacokinetic model for 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J miceToxicology Letters, 1988
- 2,3,7,8-Tetrachlorodibenzo-p-Dioxin and Related Halogenated Aromatic Hydrocarbons: Examination of the Mechanism of ToxicityAnnual Review of Pharmacology and Toxicology, 1982
- Three-generation reproduction study of rats given 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the dietToxicology and Applied Pharmacology, 1979
- Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in ratsToxicology and Applied Pharmacology, 1978
- Teratology studies with 2,4,5-trichlorophenoxyacetic acid and 2,3,7,8-tetrachlorodibenzo-P-dioxinToxicology and Applied Pharmacology, 1971